Dr. Kimberly Schulte, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 Nw 2nd St, Dimmitt, TX 79027 Phone: 806-647-3151 |
News Archive
The Norwegian biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax today announced approval by the Norwegian Medicines Agency ('Statens Legemiddelverk') to test a combination of LTX-315 and GV1001 as vaccine therapy in patients with resected tumours. Lytix Biopharma CEO Gunnar Salid states, "We are delighted to announce the approval of our joint study to test a combination of two very interesting experimental drugs.
BD (Becton, Dickinson and Company)announced today that it signed a definitive agreement to acquire HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms. The acquisition is subject to regulatory approvals and is expected to close during the first quarter of fiscal year 2010. The financial terms of the agreement were not disclosed.
Tobin's pharmacy and department store had already stocked its shelves with Easter and Mother's Day items last spring, and the staff had just placed the Christmas orders.
A team of scientists from Japan recently achieved more efficient degradation of the human serum albumin protein-;an important protein in the blood-;via high-intensity infrared irradiation, by attaching a zinc metal complex to the protein.
The AACR Annual Meeting 2013 will bring more than 17,000 scientists, advocates, industry leaders and other professionals to Washington, D.C., for the latest in breakthrough cancer science.
› Verified 6 days ago